Identification of Novel, Structurally Diverse, Small Molecule Modulators of GPR119

GPR119 drug discovery efforts in the pharmaceutical industry for the treatment of type 2 diabetes mellitus (T2DM) and obesity, were initiated based on its restricted distribution in pancreas and GI tract, and its possible role in glucose homeostasis. While a number of lead series have emerged, the p...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Assay Drug Dev Technol
Main Authors: Nieto, Ainhoa, Fernández-Vega, Virneliz, Spicer, Timothy P., Sturchler, Emmanuel, Adhikari, Pramisha, Kennedy, Nicole, Mandat, Sean, Chase, Peter, Scampavia, Louis, Bannister, Thomas, Hodder, Peter, McDonald, Patricia H.
Formato: Artigo
Idioma:Inglês
Publicado em: Mary Ann Liebert, Inc. 2018
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6065524/
https://ncbi.nlm.nih.gov/pubmed/30019946
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/adt.2018.849
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados